Literature DB >> 534074

Chronic monitoring of intracranial pressure using an in vivo calibrating sensor: experience in patients with pseudotumor cerebri.

P R Cooper, S Moody, F Sklar.   

Abstract

A number of reliable methods are available for the short term monitoring of intracranial pressure (ICP). However, the danger of infection and the need for external connections make the use of these methods for extended periods inappropriate. Most previously described devices for chronic monitoring of ICP are of limited value because of uncertain drift from zero-point readings. The Hittman-Meyer ICP sensor approaches the ideal for a long term monitoring device. It is fully implantable and is accurate over a wide range of pressures and for extended periods. It is designed so that in vivo calibration may be performed in a noninvasive fashion. We report the use of this device in eight patients with pseudomotor cerebri. It has functioned accurately for periods ranging up to 14 months after implantation and has proven to be a valuable aid in the management of these patients. (Neurosurgery, 5: 666-670, 1979).

Entities:  

Mesh:

Year:  1979        PMID: 534074     DOI: 10.1227/00006123-197912000-00003

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

Review 1.  Telemetric Intracranial Pressure Monitoring: A Systematic Review.

Authors:  Mahmoud Omidbeigi; Monireh-Sadat Mousavi; Sogol Meknatkhah; Maryam Edalatfar; Ausaf Bari; Mahdi Sharif-Alhoseini
Journal:  Neurocrit Care       Date:  2021-02       Impact factor: 3.210

2.  Intracranial pressure in patients with the empty sella syndrome without benign intracranial hypertension.

Authors:  A H Kaye; B M Tress; D Brownbill; J King
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

3.  Spectrum of benign intracranial hypertension in children and adolescents.

Authors:  A L Amacher; J D Spence
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.